Articles

Image is everything

PerkinElmer and LinaTech to provide imaging subsystems for cancer treatment
Written byAmy Swinderman
| 3 min read

WALTHAM, Mass.—With the goal to develop, implement, market and distribute imaging technologies for the treatment of certain types of cancer, technology leader PerkinElmer Inc. has partnered with LinaTech, a manufacturer of medical devices and software for treating cancer with radiotherapy.

Up to now, PerkinElmer's Medical Imaging Group has focused on making digital X-ray detectors and their components. The company has an exclusive relationship with GE Healthcare in which it provides digital detectors for all of GE's diagnostic imaging equipment. PerkinElmer has licensed some intellectual property as a result of that partnership. The group, which is headquartered in Santa Clara, Calif., and has approximately 150 employees, also makes detectors for oncology and radiotherapy systems as well as X-ray applications for industrial inspection and manufacturing.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.
3D illustration of a multicolored protein structure composed of folded ribbon-like strands against a blue and teal background with scattered spherical particles
Learn how advanced analytical methods support the characterization of antibody–C1q interactions and the qualification of analytical binding assays.